Skip to main content
Log in

Therapy-related myeloproliferative neoplasm with ETV6-PDGFRB rearrangement following treatment of acute promyelocytic leukemia

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Golub TR, Barker GF, Lovett M, Gilliland DG (1994) Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation. Cell 77(2):307–316

    Article  PubMed  CAS  Google Scholar 

  2. Latagliata R, Petti MC, Fenu S, Mancini M, Spiriti MAA, Breccia M, Brunetti GA, Avvisati G, Coco FL, Mandelli F (2002) Therapy-related myelodysplastic syndrome-acute myelogenous leukemia in patients treated for acute promyelocytic leukemia: an emerging problem. Blood 99(3):822–822

    Article  PubMed  CAS  Google Scholar 

  3. Lobe I, Rigal-Huguet F, Vekhoff A, Desablens B, Bordessoule D, Mounier C, Ferrant A, Sanz M, Fey M, Chomienne C, Chevret S, Degos L, Fenaux P (2003) Myelodysplastic syndrome after acute promyelocytic leukemia: the European APL group experience. Leukemia 17(8):1600–1604

    Article  PubMed  CAS  Google Scholar 

  4. Montesinos P, Gonzalez JD, Gonzalez J, Rayon C, de Lisa E, Amigo ML, Ossenkoppele GJ, Penarrubia MJ, Perez-Encinas M, Bergua J, Deben G, Sayas MJ, de la Serna J, Ribera JM, Bueno J, Milone G, Rivas C, Brunet S, Lowenberg B, Sanz M (2010) Therapy-related myeloid neoplasms in patients with acute promyelocytic leukemia treated with all-trans-retinoic acid and anthracycline-based chemotherapy. J Clin Oncol 28(24):3872–3879

    Article  PubMed  CAS  Google Scholar 

  5. Batzios C, Hayes LA, He SZ, Quach H, McQuilten ZK, Wall M, Campbell LJ (2009) Secondary clonal cytogenetic abnormalities following successful treatment of acute promyelocytic leukemia. Am J Hematol 84(11):715–719

    Article  PubMed  Google Scholar 

  6. Steer EJ, Cross NCP (2002) Myeloproliferative disorders with translocations of chromosome 5q31-35: role of the platelet-derived growth factor receptor Beta. Acta Haematol 107(2):113–122

    Article  PubMed  CAS  Google Scholar 

  7. Lierman E, Cools J (2007) TV6 and PDGFRB: a license to fuse. Haematologica 92(2):145–147

    Article  PubMed  CAS  Google Scholar 

  8. David M, Cross NCP, Burgstaller S, Chase A, Curtis C, Dang R, Gardembas M, Goldman JM, Grand F, Hughes G, Huguet F, Lavender L, McArthur GA, Mahon FX, Massimini G, Melo J, Rousselot P, Russell-Jones RJ, Seymour JF, Smith G, Stark A, Waghorn K, Nikolova Z, Apperley JF (2007) Durable responses to imatinib in patients with PDGFRB fusion gene-positive and BCR-ABL-negative chronic myeloproliferative disorders. Blood 109(1):61–64

    Article  PubMed  CAS  Google Scholar 

  9. Asou N, Iwanaga E, Nanri T, Mitsuya H (2010) Successful treatment with low-dose imatinib mesylate of therapy-related myeloid neoplasm harboring TEL-PDGFRB in a patient with acute promyelocytic leukemia. Haematologica 95(9):e1–e1

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jean-Valère Malfuson.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Malfuson, JV., Konopacki, J., Fagot, T. et al. Therapy-related myeloproliferative neoplasm with ETV6-PDGFRB rearrangement following treatment of acute promyelocytic leukemia. Ann Hematol 90, 1477–1479 (2011). https://doi.org/10.1007/s00277-011-1188-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-011-1188-1

Keywords

Navigation